This whitepaper explores how innovative chromatography solutions can improve aggregate removal while maintaining high product purity and yield, reducing both processing time and costs.

Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the ...

Antibody-based therapeutics play a vital role in treating a wide range of diseases, but their manufacture can be complex, requiring efficient purification strategies to support product quality and ...

Biointron can produce antibodies from gene synthesis to antibody purification in as little as two weeks, sometimes even a week, depending on the scale. “It’s very common to take five to six ...